• Ro 3306: Precision CDK1 Inhibitor for G2/M Cell Cycle Arrest

  2026-06-30

  Ro 3306 enables robust and selective control of CDK1 activity, making it indispensable for cell cycle G2/M synchronization and DNA repair mechanism studies. Harness quantified protocols, advanced troubleshooting, and cutting-edge reference insights to elevate your cancer research or mechanistic assays.

• Bismuth Subsalicylate in GI Research: Advanced Workflows & T

  2026-06-30

  Bismuth Subsalicylate unlocks high-precision modeling of gastrointestinal inflammation and membrane biology. Learn how to optimize experimental workflows and solve common issues using this high-purity, APExBIO-supplied compound.

• AZ505: SMYD2 Inhibitor Workflows for Epigenetic and Cancer R

  2026-06-29

  AZ505, a potent and selective SMYD2 inhibitor, enables reproducible interrogation of epigenetic and non-histone methylation events in cancer and fibrosis models. This guide details protocol parameters, troubleshooting, and novel strategies that leverage AZ505’s specificity and proven efficacy, empowering translational research in oncology and renal disease.

• c-Myc tag Peptide: Mechanisms, Autophagy, and Next-Gen Assay

  2026-06-29

  Explore the c-Myc tag Peptide as a molecular tool for dissecting transcription factor regulation and autophagy in immunoassays. This article reveals advanced mechanistic insights and practical assay parameters, offering researchers a unique perspective on c-Myc peptide applications.

• Ertapenem Sodium Salt: Mechanisms and Translational Strategy

  2026-06-28

  This article examines the mechanistic underpinnings and strategic applications of Ertapenem (sodium salt) for translational researchers tackling Gram-positive and Gram-negative bacterial resistance. Integrating the latest epidemiological findings on carbapenemase gene dynamics, we highlight APExBIO’s Ertapenem sodium salt as an essential research tool, deliver protocol guidance, and contextualize resistance modeling within the evolving landscape of carbapenem-resistant Enterobacter cloacae.

• EGCG Nanoparticles Enhance FLASH-RT Efficacy via DNA Damage

  2026-06-27

  This study demonstrates that functionalized EGCG-based nanoparticles (BENPs) significantly enhance the antitumor effects of ultra-high dose rate radiotherapy (FLASH-RT) by increasing DNA damage and stimulating a favorable immune response. The findings suggest a promising radiosensitizer approach for improving FLASH-RT outcomes while maintaining biosafety.

• Neuroligin 1 Loss Drives PKC-Linked Repetitive Behaviors in

  2026-06-26

  This study uncovers that Neuroligin 1 deficiency in striatal D2 medium spiny neurons leads to overactivation of protein kinase C (PKC), which drives excessive repetitive behaviors relevant to autism spectrum disorder (ASD). The findings provide direct mechanistic links between synaptic adhesion molecules, striatal circuitry, and PKC signaling in the emergence of autistic-like behaviors, suggesting new avenues for targeted intervention.

• Bone Transport Accelerates Diabetic Ulcer Healing via TGF-β1

  2026-06-26

  This study demonstrates that bone transport markedly improves diabetic foot ulcer healing by activating TGF-β1–mediated angiogenic and osteo-immune coupling. The findings clarify the central role of the TGF-β1/TGFBR1 pathway in coupling tissue repair processes, suggesting targeted pathway modulation as a promising therapeutic strategy.

• Amikacin Disulfate: Applied Workflows in Protein–Antibiotic

  2026-06-25

  Amikacin disulfate delivers unique value for dissecting the mechanisms of bacterial protein synthesis suppression and protein–antibiotic interactions. Recent advances in tritium-labeling and multimodal binding studies unlock new troubleshooting and optimization strategies for resistance research.

• Intravesical p21 mRNA-LNP Therapy for Localized Bladder Canc

  2026-06-25

  This study demonstrates that intravesical administration of p21 mRNA-loaded lipid nanoparticles (LNPs) restores tumor suppressor activity and suppresses tumor growth in non–muscle-invasive bladder cancer. The work pioneers a clinically compatible, localized gene therapy that leverages direct mRNA delivery for targeted tumor suppression, with mechanistic validation and translational promise.

• KCNE4 Modulation Alters Kv1.3 Blocker Pharmacology in Leukoc

  2026-06-24

  This study systematically investigates how the auxiliary subunit KCNE4 alters the pharmacological properties and inhibition kinetics of Kv1.3 channels, a central target in immune cell modulation. The findings reveal that KCNE4 slows the intracellular blockade kinetics of Psora 4 without affecting its binding affinity, highlighting the structural and functional complexity of Kv1.3 in leukocyte subtypes and its implications for selective immunomodulation strategies.

• Ultrasonically Powered Implantable TTF: Advancing Localized

  2026-06-23

  The referenced study introduces an ultrasonically powered, battery-free implantable Tumor Treating Field (i-TTF) system for enhanced glioblastoma therapy. By employing a shape-optimized BaTiO3 nanoparticle pyramid receiver, the device achieves superior wireless power transfer and localized electric field delivery, overcoming significant limitations of scalp-based TTF systems.

• Caspase-3 Colorimetric Assay Kit: Protocol & Troubleshooting

  2026-06-23

  The Caspase-3 Colorimetric Assay Kit enables rapid, sensitive quantification of DEVD-dependent caspase-3 activity, supporting apoptosis assay workflows in cell and tissue lysates. It is best suited for research focused on the caspase signaling pathway, apoptosis, and neurodegenerative disease models—not contexts where non-caspase-3 proteases or alternative apoptotic markers are primary endpoints.

• Mitocytosis Modulation Enhances Mitochondria-Targeted Antime

  2026-06-22

  This article examines a recent study that reveals how inhibiting mitocytosis—a stress response pathway in metastatic tumor cells—potentiates the efficacy of mitochondria-targeted drug delivery systems against breast cancer metastasis. The findings provide a mechanistic rationale for combining mitocytosis inhibition with mitochondrial damage to overcome resistance in highly migratory cancer models.

• Carboxylesterase Interference in Amplex Red-Based Mitochondr

  2026-06-22

  This study reveals that carboxylesterases can convert Amplex Red to resorufin independently of hydrogen peroxide and horseradish peroxidase, challenging the specificity of this widely used fluorescence assay for mitochondrial H2O2 measurement. The findings necessitate revised protocols and careful interpretation of prior oxidative stress data, with direct implications for redox and ROS research.

16392 records 1/1093 page Next 12345 下5页 Last page